Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome

Table 4

Comparison of levels of NT-proBNP in the subgroups with and without IR.

Variable	HOMA-IR ≤ 3.4 (without eIR)		HOMA-IR > 3.4 (with eIR)
	Mean ± SD (pg/mL)	N	Mean ± SD (pg/mL)	N
NT-proBNP age 21–65 years	32.2 ± 26.4	41	21.4 ± 25.4	38	0.014
NT-proBNP age ≤ 44 years	31.0 ± 29.5	23	14.9 ± 16.9	22	0.030
NT-proBNP age > 44 years	33.8 ± 22.6	18	30.4 ± 32.2	16	0.227

, Mann–Whitney test; HOMA-IR: homeostatic model assessment (estimated insulin resistance); NT-proBNP: amino-terminal pro-B-type natriuretic peptide.